Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment.

Genuino, Anne Julienne; Gloria, Mac Ardy Junio; Chaikledkaew, Usa; Reungwetwattana, Thanyanan; Thakkinstian, Ammarin

Genuino, Anne Julienne; Gloria, Mac Ardy Junio; Chaikledkaew, Usa; Reungwetwattana, Thanyanan; Thakkinstian, Ammarin.

Afiliação

Genuino AJ; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.
Gloria MAJ; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.
Chaikledkaew U; Department of Pharmacy, College of Pharmacy, University of the Philippines Manila, Manila, The Philippines.
Reungwetwattana T; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.
Thakkinstian A; Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.

Expert Rev Pharmacoecon Outcomes Res ; 21(5): 1001-1010, 2021 Oct.

Article em En | MEDLINE | ID: mdl-32972260

Assuntos

Antineoplásicos Imunológicos/administração & dosagem; Neoplasias da Mama/tratamento farmacológico; Trastuzumab/administração & dosagem; Antineoplásicos Imunológicos/economia; Neoplasias da Mama/economia; Quimioterapia Adjuvante/economia; Análise Custo-Benefício; Feminino; Humanos; Estadiamento de Neoplasias; Anos de Vida Ajustados por Qualidade de Vida; Receptor ErbB-2/metabolismo; Projetos de Pesquisa; Trastuzumab/economia

Palavras-chave

Adjuvant trastuzumab; HER2-positive; cost-effectiveness; early breast cancer; economic evaluation; systematic review

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Trastuzumab / Antineoplásicos Imunológicos Tipo de estudo: Health_economic_evaluation / Systematic_reviews Aspecto: Patient_preference Limite: Female / Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Tailândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google